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Introduction
The development of the vascular network plays an essential role in physiology and pathology. Three mechanisms -vasculogenesis, angiogenesis and arteriogenesis -participate in this process. Vascu logenesis occurs by angioblast differentiation into endothelial cells to form blood vessels. Angiogene sis is the process in which new blood vessels are formed from preexisting ones, and arteriogenesis refers to the enlargement of the arterial network to sustain higher metabolic demands of the tissue [19] . In oncology, tumor vascularity is correlated with tumor growth, invasion and initiation of metastasis [2] and is thought to occur mainly by angiogenesis [10] , although the role of postnatal vasculogenesis by recruitment of bone marrowderived endothelial progenitor cells (EPCs) into the tumor vasculature has also been discussed [9, 27] . Formation of a new capillary network involves many steps of a cascade in which one event triggers the next through the action of specific mediators. These mediators belong to dif ferent sets of factors participating in tumor angiogen esis. One of the sets includes numerous proinflam matory mediators such as growth factors, cytokines, proteoglycans and lipid mediators, but all of them are delivered from any cell injured by hypoxia, ischemia, free radicals or infection agents. The other, recent ly studied, set of angiogenic mediators comprises those that are fragments of destroyed host necrotic cells. Such mediators were recognized as the dam ageassociated molecular pattern (DAMP) molecules that have been implicated in several inflammatory diseases and activate target cells through the dif ferential engagement of multiple surface receptors including innate immune receptors such as Tolllike receptor 2 (TLR2), or receptor for advanced glycation endproducts (RAGE). In addition, mast cells, which are abundant surrounding solid tumors, are a source of numerous compounds that are often suspected of participation in tumor angiogenesis. Recently, we observed that TLR2 is a very sensitive marker of a newly formed tumor capillary network in medullo blastoma [28] .
Medulloblastoma is the most common primary solid brain tumor occurring in children, with a strong male preponderance. Histologically, the tumor is composed of sheets or lobules of small cells with prominent nuclei and little cytoplasm. Vascular prolif eration may be present but is not a constant feature of this lesion, but as in other tumors neovasculariza tion is an important mechanism underlying medullo blastoma progression. Increased tumor angiogene sis is normally associated with poor prognosis of the disease, and the development of therapeutic agents that can reduce or inhibit angiogenesis or destroy the neovasculature of tumors has recently received considerable interest [31] . One possible advantage of these drugs, compared with conventional chemo therapy, is their potential for reduced susceptibility to acquired drug resistance. This is a major clinical problem observed in patients undergoing chemo therapy and results from the intrinsic genetic insta bility and heterogeneity of tumor cells [29] . Endothe lial cells, on the other hand, on which antivascular and antiangiogenic drugs act, are genetically more stable and more homogeneous and are thus pre sumed to be not so susceptible to acquired drug resistance. Our growing understanding of the mole cular mechanisms underlying angiogenesis, includ ing the role of several growth factors that regulate the process, has enabled the development of a large number of drug candidates against vascularspecific targets that can inhibit angiogenesis.
Since there are numerous unanswered questions concerning the process of angiogenesis which occurs in the pathological microenvironment of cancer, the aim of our present study was to examine in medul loblastoma of the human brain the distribution of TLR2 and RAGE receptors and mast cells associated with the tumor neovascularization.
Material and methods
The study was approved by the local ethical com mittee and performed on human brains that were obtained following autopsy. Patients died at differ ent ages of life (from 15, 17, to 37 years of age), one to two years after ineffective therapy. Brains with medulloblastoma were diagnosed according to the WHO classification [26] in the Institute of Medical Research Centre, Polish Academy of Sciences, War saw, Poland. Paraffin blocks were drawn from the file, cut into serial sections (5 μm thick) and stained with H&E for routine histological examination or used for immunohistochemical study.
Immunohistochemistry
Immunohistochemistry was performed using specific primary antibodies and an alkaline phos phataseavidinbiotin conjugate purchased from Santa Cruz Laboratory (USA) or an avidinbiotinper oxidase complex system purchased from Vector Lab oratories (USA) and used according to the manufac turer's recommendations.
Briefly, sections were dewaxed and hydrated through descending alcohols to water. For nonen zymatic antigen retrieval, some sections were heat ed in 0.01 M sodium citrate buffer (pH 6.0) to 95°C and allowed to cool for 20 min at room temperature and washed with PBS. Then, they were incubated in methanol/3% H 2 O 2 solution for 20 min to quench endogenous peroxidase. After being washed again in PBS and blocked with solution containing PBS/5% appropriate normal serum (of goat, rabbit or mouse) for 2 h at room temperature, sections were incubat ed overnight at 4°C in solutions of primary antibod ies listed in Table I .
Immunoreactions were visualized using biotinylat ed secondary antibodies and ABComplex/HRP or an alkaline phosphataseavidinbiotin conjugate. Then, sections were lightly counterstained with Mayer's hematoxylin.
For negative controls, primary antibodies were replaced with an appropriate isotypic normal mouse, rabbit or goat immunoglobulin fraction at a matched protein concentration. These were included for the examination of each specimen and consistently pro duced negative results.
Results
Distribution of the TLR2 capillary network, mast cells and RAGE in different regions of medulloblasto ma is presented in Table II .
In medulloblastoma of all our patients, neovas cularization/angiogenesis (V/A) was observed in areas of tumor cell necrosis. We observed the suc cessive steps of this process. Cells participating in each such step were immunopositive to TLR2. At the beginning, TLR2 immunopositive cells were scat tered throughout the tumor necrotic debris (Fig. 1A) . In the next step, they formed tubular structures (Fig. 1B) which penetrated to the postnecrotic areas already cleared of dead cells (Fig. 1C) . Finally, numer ous TLR2immunopositive capillaries formed a very dense vascular network which closely conforms to the postnecrotic space of the tumor (Fig. 2) . In the capillary wall of this network RAGE receptors were not found. In addition, mast cells were not detected in these necrotic or postnecrotic areas of the tumor.
In noninjured regions of the medulloblastoma, the vascular network was immunonegative to TLR2, but RAGE protein was precisely localized in the wall of all capillaries and in proliferating endothelium of some of these vessels (Fig. 3AB) .
Mast cells were distributed at the border of the medulloblastoma and were localized at the perivas cular space of large brain vessels (Fig. 4A) . Those mast cells that were detected within the solid tumor regions belonged to the host meninges that were incorporated into the tumor mass (Fig. 4B ).
Discussion
Reciprocity of inflammation and neovascular ization is emerging as an important mechanism underlying numerous processes from tissue healing/ remodeling to cancer [3, 17] .
In recent years, antiangiogenic therapies have been developed and tested for their effectiveness against tumors. Among such drugs are inhibitors against vascular endothelial growth factor and its receptors, as well as inhibitors targeting the plate letderived growth factor family, integrins or histone deacetylase. While many antiangiogenic drugs have been shown to be effective with limited toxicity, some tumors are able to adopt escape mechanisms [24] , suggesting that the vascular network in some tumors could be formed in a different way than normal cap illaries. The results of our present study confirm this hypothesis. In regions of medulloblastoma cell necro sis, we observed that TLR2 participates in all steps of vascular network formation, but in regions where the tumor was not affected by necrosis, the capil lary network was TLR2 immunonegative. We believe that all those TLR2 immunonegative capillaries were developed during normal host embryogenesis and the space supplied by this capillary network was colo nized by medulloblastoma cells. Thus, only in necrotic areas of the medulloblastoma were pathogens deliv ered from dying undifferentiated tumor cells recog nized by TLR2 and activated TLR2 signaling promoted the angiogenic responses in the tumor. Tolllike receptors (TLRs) are a family of pattern recognition receptors that have emerged as key mediators of innate immunity. These receptors rec ognize a broad range of protein and lipid ligands [21, 33] , including a number of host origin ligands [1, 18, 22, 36, 37, 41] , and initiate host defense inflam mation. TLRmediated inflammation is an import ant pathogenic link between innate immunity and a diverse panel of clinical disorders including cancer. In addition, expression of TLR2 and TLR4 was found on the endothelium; therefore both receptors, in some circumstances, may be implicated in angiogenesis [8] .
Altogether our results indicate that TLR2 is a sen sor of pathogens of necrotic tumor cells, which pro vides a key link connecting innate immunity and cancer angiogenesis.
Tumorigenesis is a multistep process involving the alternation of a number of key cellular properties including uncontrolled proliferation, evasion of cell death (apoptosis), vascularization (angiogenesis) and subsequent invasion and migration of tumor cells into the surrounding tissues [10] . Understand ing the molecular processes underlying these cellu lar phenotypic changes is critical in order to develop novel therapies. Central to mediating these changes is the interaction between cell surface receptors and their cognate ligands, which through intracellular signaling induce alternations in gene expression. In this context, recent studies have identified that the receptor for advanced glycation endproducts (RAGE) and its ligands may play an important role in cancer [7, 25, 38, 39] . RAGE is a multiligand receptor that has been implicated in the pathogenesis of numerous diseases [20, 38, 42] . RAGEligand interaction triggers activation of a diverse array of signaling pathways that lead to processes integrally linked to the tum origenic sequelae including cellular migration, inva sion, proliferation and survival [25, 29] . Furthermore, A B studies have indicated that RAGE and its ligands are expressed in human tumors, and often the extent of tumor invasiveness and metastatic potential was correlated with the degree of RAGE/ligand upregu lation [1116, 23, 30, 35, 40] . Brain compartments are effectively isolated from the plasma proteins and various ligands by the blood brain barrier (BBB), localized on the endothelium of the brain capillaries. However, at this barrier, there are specialized receptors including RAGE that may shuttle all such proteins in efflux and influx direc tions [4, 5] . The results of our present study suggest that RAGE does not participate in the bloodbrain function of the capillary network formed in postne crotic regions of the medulloblastoma and ligands of this receptor cannot affect the healing process of the tumor. However, in all other regions of the tumor, RAGE is present on capillary endothelium, and thus the bloodbrain barrier functions differently than in postnecrotic areas. In addition, mast cells, known as a source of earlyresponse cytokines decisive in initiating the immune and host defense reaction to pathogens, were not found in the vicinity of capillar ies in any regions of the tumor. Despite many reports concerning the association of mast cells (MC) with a variety of tumors, the functional significance of these cells in tumor biology remains obscure. The pre sence of mast cells has been interpreted as an immu nological antitumor response or as a more direct interaction with tumor cells, especially an interaction which facilitates tumor growth [32] . The results of our study suggest that mast cells have little if any influ ence on development of angiogenesis in postnecrotic regions of the medulloblastoma.
Mast cells are a heterogeneous cell population categorized as either mucosal type or connective tissue type, based on their tissue locations, stain ing patterns, content of proteases and reactivity. In humans, mature mast cells in the brain contain tryptase as a protease and are known as the MC tryptase phenotype (MCT) [34] . Mast cells provide different multifunctional cytokines and potent mediators can mediate a variety of antimicrobi al functions and possess certain unique features that make MC function particularly crucial for host defense [6] . Mast cells are always located at the hostenvironment interface, and they belong to the first line of cells that encounter pathogens. In our study, we found many of these cells at the border of the tumor and in meninges that covered the tumor. All MC were located at the perivascular space of large blood vessels. Therefore we conclude that MC were not directly involved in the function of the bloodbrain barrier or in the process of angio genesis of medulloblastoma postnecrotic areas. However, MC are longlived cells with the capacity to respond repeatedly to the same stimulus, and we suspect that in our patients they had a potent influ ence on the function of the vascular network at the peripheral regions of the tumor.
Medulloblastomas are characterized by poor pro gnosis and low patient survival rates. In particular, strong induction of angiogenesis marks the transi tion from a lowergrade medulloblastoma to a more aggressive and lethal form of the tumor. Although these tumors rarely metastasize, they almost always recur locally. Data from our study suggest that this may be linked with angiogenesis and the healing process in medulloblastoma necrotic areas.
Despite advanced clinical approaches with sur gery, radiotherapy and chemotherapy, inhibition of angiogenesis might represent a key strategy in the treatment of this neoplasm.
Nevertheless, the success with existing com pounds in the managements of brain tumors is lim ited, and further study is required. We present new data focused on tumor angiogenesis. They show that capillary network formation and function of the bloodbrain barrier differ depending on the medullo blastoma region and that receptors of innate immu nity play an essential role in these processes.
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